Immunosuppression is a well-recognized cause of skin tumors, in particular squamous cell carcinomas (SCC). In patients with hematological malignancies undergoing chemotherapy, SCC has been reported late in the course of the disease or many years after completion of treatment. Here we report a patient with acute myeloid leukemia who developed a SCC of the tongue while receiving the third course of induction chemotherapy. This is the second such case in the medical literature. The role of immunosuppression, chemotherapy, the malignancy itself and possible genetic predisposition is discussed and the literature on this topic is reviewed.
LeoneG., MeleL., PulsoniA., EquitaniF., PaganoL.: The incidence of secondary leukemia.Haematologica,84: 937–945, 1999.
2.
LevineE.G., BloomfieldC.D.: Leukemias and myelodysplastic syndromes secondary to drug, radiation and environmental exposure.Semin Oncol,19: 47–84, 1992.
3.
RubinC.M., ArthurD.C., WoodsW.G., LangeB.J., NowellP.C., RowlyJ.D.: Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy.Blood,78: 2982–2988, 1991.
4.
SalloumE., DoriaR., SchubertW., ZeltermanD., HolfordT., RobertsK.B., FarberL.R., KiehlR.K., CardinaleJ., CooperD.L.: Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.J Clin Oncol,14: 2435–2443, 1996.
5.
MoreheadJ.M., ParsonsD.S., McMahonD.P.: Squamous cell carcinoma of the tongue occurring as a subsequent malignancy in a 12 years old acute leukemia survivor.Int J Pediatr Otorhinolaryngol,26: 89–94, 1993.
6.
KottaridisP.D., GoldstoneA.H.: Development of squamous cell carcinoma of the skin during induction chemotherapy for acute myeloid leukemia.Leuk Lymphoma,43: 459–460, 2002.
7.
PreislerH., DavisR.B., KirshnerJ., DupreE., RichardsF., HoaglandH.C., KopelS., LevyR.N., CareyR., SchulmanP.: Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study.Blood,69: 1441–1449, 1987.
8.
SpadeaA., PettiM.C., FaziP., VegnaM.L., ArceseW., AvvisatiG., Aloe SpiritiM.A., LatagliataR., MeloniG., TestiA.M.: Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.Leukemia,7: 549–552, 1993.
9.
BoivinJ.F., HutchisonG.B., ZauberA.G., BernsteinL., DavisF.G., MichelR.P., ZankeB., TanC.T., FullerL.M., MauchP.: Incidence of second cancers in patients treated for Hodgkin's disease.J Natl Cancer Inst,87: 732–741, 1995.
10.
NegliaJ.P., MeadowsA.T., RobisonL.L., KimT.H., NewtonW.A., RuymannF.B., SatherH.N., HammondG.D.: Second neoplasms after acute lymphoblastic leukemia in childhood.N Engl J Med,325: 1330–1336, 1991.
11.
KrauseJ.R., AyuyangH.Q., EllisL.D.: Secondary nonhematopoietic cancers arising following treatment of hematopoietic disorders.Cancer,55: 512–515, 1985.
12.
NagashimaT., MuroiK., KunitamaM., IzumiT., OhtsukiT., KomatsuN., FukayamaM., OzawaK.: Colon cancer with meningeal carcinomatosis and myelodysplastic syndrome in a patient who underwent intensive chemotherapy for acute myelogenous leukemia: a case report.Jpn J Clin Oncol,31: 221–225, 2001.
13.
JensenP., HansenS., MollerB., LeivestadT., PfefferP., GeiranO., FauchaldP., SimonsenS.: Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.J Am Acad Dermatol,40: 177–186, 1999.
14.
LishnerM., PattersonB., KandelR., FylesG., CurtisJ.E., MeharchandJ., MindenM.D., MessnerH.A.: Cutaneous and mucosal neoplasms in bone marrow transplant recipients.Cancer,65: 473–476, 1990.
15.
ShawM.P., WallaceW.H.B., EdenO.B.: Spindle cell carcinoma of the tongue in a long-term survivor of childhood acute lymphoblastic leukemia.Pediatr Hematol Oncol,14: 79–83, 1997.
16.
BlottW.J., McLaughlinJ.K., WinnD.M.: Smoking and drinking in relation to oral and pharyngeal cancer.Cancer Res,48: 3282–3287, 1988.
17.
WangX.M., McNiffJ.M., KlumpV., AsgariM., GasparroF.P.: An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA.Photochem Photobiol,66: 294–299, 1997.
18.
WeeksD.E., PatersonM.C., LangeK.: Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia.Radiat Res,128: 90–99, 1991.
19.
KesslerS., BartleyM.: Spindle cell squamous cell carcinoma of the tongue in the first decade of life.Oral Surg,66: 470–474, 1988.
20.
OchsJ., MulhernR.K.: Late effects of antileukemic treatment.Pediatr Clin North Am,35: 815–833, 1988.
21.
RamsayH.M., FryerA., StrangeR.C., SmithA.G.: Multiple basal cell carcinomas in a patient with acute myeloid leukemia and chronic lymphocytic leukemia.Clin Exp Dermatol,24: 281–282, 1999.
22.
HankeyB.F., FraumeniJ.F.: Second cancers in patients with chronic lymphocytic leukemia.J Natl Cancer Inst,84: 1422–1427, 1992.
